This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kim, E.-J. Articles by Shin, W.-H. Search for Related Content PubMed PubMed Citation Articles by Kim, E.-J. Articles by Shin, W.-H. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Antibiotics Social Bookmarking                         What's this?

Electrophysiological safety of DW-286a, a novel fluoroquinolone antibiotic agent

Department of Pharmacology and National Research Laboratory, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Yuseong, Daejeon, Korea; Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Yuseong, Daejeon 305-343, Korea ejkim{at}kitox.re.kr

Ki-Suk Kim

Won-Ho Shin

Department of Pharmacology and National Research Laboratory, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, Yuseong, Daejeon, Korea

Inhibition of the potassium current I _Kr, and QT prolongation has been known to be associated with drug-induced torsades de pointes arrhythmias (TdP) and sudden cardiac death. We investigated the cardiac electrophysiological effects of DW-286a, a new class of fluoroquinolone antibiotics reported to prolong the QT interval. To investigate the electrophysiological safety of DW-286a, we used conventional microelectrode recording techniques in isolated guinea pig papillary muscles, whole-cell patch clamp techniques in human ether-á-go-go related gene (hERG)-transient transfected Chinese hamster ovary cells, and in vivo electrocardiogram (ECG) measurements in Sprague-Dawley (SD) rats by the use of a telemetry system. DW-286a at 300 µM significantly (P <0.01) prolonged action potentials at 50% repolarization (APD₅₀) and 90% repolarization (APD₉₀). For I _HERG, the IC₅₀ value was 89.00±37.85 µM with a Hill coefficient (n ^H) of –0.97 ±0.49. However, when DW-286a was orally administered to conscious SD rats at a high dose (1000 mg/kg), no significant effect on ECG in vivo was detected. From a previous study, we know that concentration at 19.8 µM is the antimicrobial end-point of DW-286a. Therefore, our data suggest that in the electrophysiological aspect, it can be thought that the effective concentrations of DW-286a are between 19.8 and 100 µM (concentration in serum).

Key Words: DW-286a • Fluoroquinolone • human ether-á-go-go related gene (hERG) • QT prolongation • patch clamp techniques

Human & Experimental Toxicology, Vol. 24, No. 1, 19-25 (2005)
DOI: 10.1191/0960327105ht494oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?